Arrowhead Research | ARWR - Trade Debtors


Arrowhead Research reported $15.68M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 15.68M 203.19M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Incyte USD 1.05B 27.09M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Merck USD 11.78B 345M Dec/2025
Moderna USD 71M 113M Mar/2026
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
TG Therapeutics USD 392.05M 86.42M Mar/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Xencor USD 12M 17.3M Mar/2026